Gabapentin

CAT:
804-HY-A0057-01
Size:
10 mg

For Laboratory Research Only. Not for Clinical or Personal Use.

  • Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
  • Dry Ice Shipment: No
Gabapentin - image 1

Gabapentin

  • Description:

    Gabapentin is a potent, orally active P/Q type Ca2+ channel blocker. Gabapentin inhibits neuronal Ca2+ influx and reduction of neurotransmitter release. Gabapentin is a GABA analog that can be used to relieve neuropathic pain[1][2][3].
  • UNSPSC:

    12352211
  • Hazard Statement:

    H315, H319, H335, H360
  • Target:

    Calcium Channel
  • Type:

    Reference compound
  • Related Pathways:

    Membrane Transporter/Ion Channel; Neuronal Signaling
  • Applications:

    Neuroscience-Neuromodulation
  • Field of Research:

    Neurological Disease; Cancer
  • Assay Protocol:

    https://www.medchemexpress.com/Gabapentin.html
  • Purity:

    99.49
  • Solubility:

    DMSO : 1 mg/mL (ultrasonic) |H2O : 50 mg/mL (ultrasonic)
  • Smiles:

    O=C(O)CC1(CN)CCCCC1
  • Molecular Formula:

    C9H17NO2
  • Molecular Weight:

    171.24
  • Precautions:

    H315, H319, H335, H360
  • References & Citations:

    [1]Fink K, et, al. Inhibition of neuronal Ca (2+) influx by gabapentin and subsequent reduction of neurotransmitter release from rat neocortical slices. Br J Pharmacol. 2000 Jun;130 (4) :900-6.|[2]Celikyurt IK, et, al. Gabapentin, A GABA analogue, enhances cognitive performance in mice. Neurosci Lett. 2011 Apr 1;492 (2) :124-8.|[3]Meymandi MS, et, al. Gabapentin action and interaction on the antinociceptive effect of morphine on visceral pain in mice. Eur J Anaesthesiol. 2008 Feb;25 (2) :129-34.
  • Shipping Conditions:

    Room Temperature
  • Storage Conditions:

    Store at room temperature 3 years
  • Scientific Category:

    Reference compound1
  • Clinical Information:

    Launched
  • Citation 01:

    ACS Pharmacol Transl Sci. 2023 Mar 6;6 (4) :519-525.|Br J Pharmacol. 2025 Aug 9.|Cell Rep. 2019 Dec 17;29 (12) :3847-3858.e5.|iScience. 2023 Jul 3;26 (8) :107264.|J Nat Med. 2022 Jan;76 (1) :268-275.|J Pain. 2019 May;20 (5) :577-591. |Mol Biol Rep. 2025 Sep 3;52 (1) :859.|Neuropharmacology. 2024 Dec 21:110276.|Pharmacol Res Perspect. 2021 Oct;9 (5) :e00879.|Sci Total Environ. 2022 Jul 10;829:154437.|Eur J Drug Metab Pharmacokinet. 2022 Sep;47 (5) :639-652.
  • CAS Number:

    [60142-96-3]